Supplements and Featured Publications
Genomic Testing in Oncology to Improve Clinical Outcomes While Optimizing Utilization: the Evolution
Volume: 22
Issue: 2 Suppl
Case Study: Therapeutic Interchange in Patients Being Treated for Opioid Dependence
Exclusive Coverage of the 57th American Society of Hematology Annual Meeting and Exposition in Orlan
2015 Winter Cardiology Conference Review
The Evolution of Prostacyclins in Pulmonary Arterial Hypertension: From Classical Treatment to Moder
Volume: 22
Issue: 1 Suppl
Clinical and Managed Care Implications of Biosimilars: Evaluating the Science and Challenges to Upta
Volume: 21
Issue: 16 Suppl
![Special Issue: Product Pipeline Review [December 2015]](https://cdn.sanity.io/images/0vv8moc6/ajmc/c86b6a1c18f56c6ad4f34612482390855275bf2f-1675x2156.jpg?w=230&fit=crop&auto=format)
Special Issue: Product Pipeline Review [December 2015]
Volume: 21
NAMCP 2015 Conference Coverage
Volume: 21
The Burden of Hyperkalemia in Patients With Cardiovascular and Renal Disease
Volume: 21
Issue: 15 Suppl
Keeping Pace With the Evolving Treatment Landscape in Idiopathic Pulmonary Fibrosis
Volume: 21
Issue: 14
Understanding the Diagnosis, Management, and Treatment Options for Neurogenic Orthostatic Hypoten
Volume: 21
Issue: 13
Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Chal
Volume: 21
Issue: 12 Suppl
Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin
Volume: 21
Issue: 11 Suppl
Use of Opioid Analgesics in Managed Care Practice: Challenges, Controversies, REMS, and Optimizing P
Volume: 21
Issue: 9 Suppl
Parkinson’s Disease Psychosis: Symptoms, Management, and Economic Burden
Volume: 21
Issue: 10 Suppl
The Evolving Treatment Landscape and Innovative Payment Models in Oncology: An Expert Summit
Reductions in Mortality Among Medicare Beneficiaries Following the Implementation of Medicare Part D
Volume: 21
Issue: 9 Suppl
Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?
Volume: 21
Issue: 8 Suppl
ADA 2015 Conference Coverage
![Special Issue: Product Pipeline Review [June]](https://cdn.sanity.io/images/0vv8moc6/ajmc/eeaf31968f6213cadba3d4100dae372938facbce-3347x4569.png?w=230&fit=crop&auto=format)
Special Issue: Product Pipeline Review [June]
Volume: 21
The Evidence Behind the Evidence: A Deeper Dive Into the Management of Chronic Heart Failure
Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection
Volume: 21
Issue: 7 Suppl
![Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/05019000301109976bb5bd6b274a4f5482f94f89-900x1229.jpg?w=230&fit=crop&auto=format)
Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]
Volume: 21
Issue: 6 Suppl
Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations [CME
Volume: 21
Issue: 5 Suppl
Economic Evaluation of a Fluocinolone Acetonide Intravitreal Implant for Patients With DME Based on
Volume: 21
Issue: 4 Suppl
Characterizing Pulmonary Hypertension–Related Hospitalization Costs Among Medicare Advantage or Co
Volume: 21
Issue: 3 Suppl
Standards of Care Issues With Anticoagulation in Real-World Populations
Volume: 21
Issue: 2 Suppl
![Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/371bb77085a8399820783447221ceeedad255a69-900x1229.jpg?w=230&fit=crop&auto=format)
Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]
Volume: 21
Issue: 1 Suppl
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Volume: 20
Issue: 14 Suppl
Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Anal
Volume: 20
Issue: 13 Suppl
Advertisement
Advertisement
Trending on AJMC
1
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
2
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
3
Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color
4
FDA Approves Second Generic Mifepristone Pill for Abortion
5
